Who is sponsoring NCT03210571?

NCT03210571 is sponsored by Rheon Medical SA.

What condition does NCT03210571 study?

NCT03210571 studies Open Angle Glaucoma.

What drugs are being tested in NCT03210571?

Interventions: eyeWatch system.

What is the status of NCT03210571?

NCT03210571 is currently COMPLETED.

Last reviewed 2021-10-28 · How we verify

Clinical Investigation of the eyeWatch Glaucoma Drainage Device

NCT03210571 NA COMPLETED

This study aims to test a new medical device, called the eyeWatch, used in filtering surgery for the treatment of glaucoma. This medical device has the following property: it allows better control of intraocular pressure in the initial postoperative phase by adjusting aqueous flow going through the device. The target criteria for the study are defined as: keeping intraocular pressure in target range; reducing the number of anti-glaucoma drugs; evaluating the number and type of postoperative complications. So far, this device has been already tested on 20 patients in Switzerland.

Details

Lead sponsor	Rheon Medical SA
Phase	NA
Status	COMPLETED
Enrolment	27
Start date	Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Open Angle Glaucoma

Interventions

eyeWatch system

Countries

United Kingdom